Ann Transl Med, 2021 · DOI: 10.21037/atm-21-2874 · Published: July 1, 2021
Spinal cord injury (SCI) can lead to movement and sensory problems, as well as anxiety and depression. Current treatments have limited success in restoring nerve function. This study explores using GelMA hydrogel to help nerve repair and regeneration in mice with SCI. GelMA hydrogels have properties that can encourage cell growth. They are similar to natural materials in the body and can be quickly crosslinked to form a support structure for cells. This study examines the effects of directly injecting GelMA hydrogel on nerve repair in mice with SCI. The study found that GelMA hydrogel improved movement, lengthened nerve cell axons, reduced syringomyelia, and modulated protein expression related to nerve repair. These results suggest GelMA hydrogel could be a useful treatment for SCI.
GelMA hydrogel could be explored as a therapeutic agent for spinal cord injury to promote nerve regeneration and functional recovery.
The study suggests that GelMA hydrogel can inhibit scar formation and reduce syringomyelia, which are key factors hindering nerve regeneration after SCI.
The improvement in BMS scores indicates that GelMA hydrogel can contribute to the recovery of limb movement function in SCI patients.